Skip to main content
. Author manuscript; available in PMC: 2018 Oct 15.
Published in final edited form as: J Immunol. 2017 Sep 15;199(8):2885–2895. doi: 10.4049/jimmunol.1700870

Figure 4. HSV-2 infection differentially modulates FM cytokine/chemokine responses to LPS.

Figure 4

Human FM explants were treated with no treatment (NT), LPS (100ng/ml), HSV-2 (6.4×102/ml PFU) or both HSV-2 and LPS (n=3). Supernatants were measured by multiplex analysis. *p<0.05 relative to the NT control unless otherwise indicated. Data are expressed as mean±SEM.